HG
Therapeutic Areas
Oniria Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ONR-001 | Cancer Persistence (Colorectal Cancer, Melanoma mentioned) | Pre-clinical |
Leadership Team at Oniria Therapeutics
ER
Esther Riambau
Co-Founder and Chief Executive Officer
IP
Isabel Puig
Co-Founder and Scientific Advisor for new therapeutic targets
XB
Xavier Barril
Co-Founder and Scientific Advisor in computational chemistry
CG
Carlos Galdeano
Co-Founder and Scientific Advisor in drug discovery
JT
Josep Tabernero
Co-Founder and Clinical Advisor